Prime Minister Jeong Sye-gyun is all speaking at the new coronavirus infection (Corona 19) vaccine and treatment situation check meeting held at the Government Complex Sejong on the afternoon of the 9th. Newsis
Pfizer’s new coronavirus infection (Corona 19) vaccine, contracted with the global vaccine co-purchase organization,’CoVax Facility’, is expected to be delivered from mid-February to early March. The government’s expectation that the first Corona 19 vaccine to enter Korea would be a Pfizer product was missed.
Prime Minister Jeong Sye-gyun said at the Corona 19 vaccine/treatment situation check meeting presided at the Government Complex Sejong on the 9th that the timing of the introduction of Pfizer’s vaccine in Korea through CoVax was “expected to be in late February and early March.”
Prime Minister Chung said on the 31st of last month that the COVAX Pfizer vaccine will be available as early as mid-February. However, even after February has passed, the government has not received a specific date of introduction from Kovacs. In the end, the Korea Centers for Disease Control and Prevention Chung Eun-kyung said on the 8th, “Because it is the first quantity, a contract between Kovacs and Pfizer must be made, and we must also discuss transportation plans with Pfizer.” “There are administrative procedures that are difficult for us to control. There is room.”
Eventually, the schedule for the’mid-February supply’ of the COVAX Pfizer vaccine could not be met. As the contracts with individual vaccine manufacturers were delayed, the situation became difficult for the government, which was expecting the quantity to be introduced through COVAX. An official from the Korea Centers for Disease Control and Prevention also complained that “Cobox’s decision-making system is complicated and slow.” In order for the government to achieve the goal of’November collective immunity’, it is expected that the introduction of the vaccine contracted with individual companies should be as soon as possible.
As a result, the Corona 19 vaccine that will be vaccinated for the first time in Korea has become AstraZeneca’s product. Of the 10 million vaccines the government has decided to introduce through an individual contract with AstraZeneca, 750,000 will be delivered over the 24-28th of this month. This is a product produced by SK Bioscience, which has signed a consignment production contract with AstraZeneca.
Prime Minister Chung said, “The first vaccination will begin at the end of February with the AstraZeneca vaccine produced directly in Korea.” We are carefully preparing the entire process,” he said.
Song Okjin reporter [email protected]
Lim So-hyung reporter [email protected]
Subscribe to the Hankook Ilbo News Naver Channel
Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo